Welcome to LookChem.com Sign In|Join Free

CAS

  • or
16-Dehydropregnenolone Oxime, also known as Glucorticoid Mifepristone Antagonist, is a derivative of pregnenolone, a key precursor in the biochemical synthesis of progesterone. It possesses significant anti-inflammatory and anti-proliferative properties, making it a promising therapeutic agent for various conditions, including cancer and autoimmune disorders. Originally intended for hormone replacement therapy in women as progesterone, it has also been found to have potential applications in emergency contraception when administered at high doses.

1045-71-2 Suppliers

Post Buying Request

Recommended suppliersmore

  • Product
  • FOB Price
  • Min.Order
  • Supply Ability
  • Supplier
  • Contact Supplier
  • (3s,8r,9s,10r,13s,14s)-17-[(z)-n-hydroxy-c-methylcarbonimidoyl]-10,13-dimethyl-2,3,4,7,8,9,11,12,14,15-decahydro-1h-cyclopenta[a

    Cas No: 1045-71-2

  • No Data

  • 5 Kilogram

  • 100 Kilogram/Week

  • Career Henan Chemical Co
  • Contact Supplier
  • 1045-71-2 Structure
  • Basic information

    1. Product Name: 16-DEHYDROPREGNENOLONE OXIME
    2. Synonyms: 3-Hydroxypregna-5,16-dien-20-one oxime;5,16-Pregnenolone oxime;Pregn-5,16-dienolone 20-oxime;3BETA-HYDROXY-5,16-PREGNADIEN-20-ONE OXIME;5,16-PREGNADIEN-3BETA-OL-20-ONE OXIME;5,16-PREGNADIEN-3-BETA-OL-20-ONE 20-OXIME;16-DEHYDROPREGNENOLONE OXIME;16-dehydropregnenolone oxime*crystalline
    3. CAS NO:1045-71-2
    4. Molecular Formula: C21H31NO2
    5. Molecular Weight: 329.48
    6. EINECS: N/A
    7. Product Categories: N/A
    8. Mol File: 1045-71-2.mol
  • Chemical Properties

    1. Melting Point: N/A
    2. Boiling Point: 489.3 °C at 760 mmHg
    3. Flash Point: 325.2 °C
    4. Appearance: /
    5. Density: 1.24 g/cm3
    6. Refractive Index: N/A
    7. Storage Temp.: N/A
    8. Solubility: N/A
    9. CAS DataBase Reference: 16-DEHYDROPREGNENOLONE OXIME(CAS DataBase Reference)
    10. NIST Chemistry Reference: 16-DEHYDROPREGNENOLONE OXIME(1045-71-2)
    11. EPA Substance Registry System: 16-DEHYDROPREGNENOLONE OXIME(1045-71-2)
  • Safety Data

    1. Hazard Codes: N/A
    2. Statements: N/A
    3. Safety Statements: N/A
    4. WGK Germany: 3
    5. RTECS:
    6. HazardClass: N/A
    7. PackingGroup: N/A
    8. Hazardous Substances Data: 1045-71-2(Hazardous Substances Data)

1045-71-2 Usage

Uses

Used in Pharmaceutical Industry:
16-Dehydropregnenolone Oxime is used as a hormone replacement therapy for women, providing progesterone to support reproductive health and address hormonal imbalances.
Used in Oncology:
16-Dehydropregnenolone Oxime is used as an anti-cancer agent, exhibiting significant anti-proliferative properties that can help inhibit the growth and progression of various types of cancer.
Used in Autoimmune Disorders:
16-Dehydropregnenolone Oxime is used as an immunomodulatory agent, leveraging its anti-inflammatory properties to manage and treat autoimmune disorders by reducing inflammation and modulating the immune system's response.
Used in Emergency Contraception:
16-Dehydropregnenolone Oxime is used as an emergency contraceptive when administered at high doses, preventing pregnancy by interfering with the normal reproductive process.

Check Digit Verification of cas no

The CAS Registry Mumber 1045-71-2 includes 7 digits separated into 3 groups by hyphens. The first part of the number,starting from the left, has 4 digits, 1,0,4 and 5 respectively; the second part has 2 digits, 7 and 1 respectively.
Calculate Digit Verification of CAS Registry Number 1045-71:
(6*1)+(5*0)+(4*4)+(3*5)+(2*7)+(1*1)=52
52 % 10 = 2
So 1045-71-2 is a valid CAS Registry Number.

1045-71-2SDS

SAFETY DATA SHEETS

According to Globally Harmonized System of Classification and Labelling of Chemicals (GHS) - Sixth revised edition

Version: 1.0

Creation Date: Aug 16, 2017

Revision Date: Aug 16, 2017

1.Identification

1.1 GHS Product identifier

Product name (3S,8R,9S,10R,13S,14S)-17-[(Z)-N-hydroxy-C-methylcarbonimidoyl]-10,13-dimethyl-2,3,4,7,8,9,11,12,14,15-decahydro-1H-cyclopenta[a]phenanthren-3-ol

1.2 Other means of identification

Product number -
Other names 5,16-Pregnadien-3beta-ol-20-one oxime

1.3 Recommended use of the chemical and restrictions on use

Identified uses For industry use only.
Uses advised against no data available

1.4 Supplier's details

1.5 Emergency phone number

Emergency phone number -
Service hours Monday to Friday, 9am-5pm (Standard time zone: UTC/GMT +8 hours).

More Details:1045-71-2 SDS

1045-71-2Relevant articles and documents

Synthesis and evaluation of novel steroidal oxime inhibitors of P450 17 (17α-hydroxylase/c17-20-lyase) and 5α-reductase types 1 and 2

Hartmann,Hector,Haidar,Ehmer,Reichert,Jose

, p. 4266 - 4277 (2000)

17α-Hydroxylase/C17-20-lyase (P450 17, CYP 17) and 5α-reductase are the key enzymes in androgen biosynthesis and targets for the treatment of prostate cancer and benign prostatic hyperplasia. In the search of inhibitors for both enzymes, 23 pregnenolone- or progesterone-based steroids were synthesized bearing an oxime group connected directly or via a spacer to the steroidal D-ring. Tested for inhibition of human and rat P450 17, some pregnenolone (9, 11, 14) and a series of progesterone compounds (17-20) turned out to be highly active inhibitors of the human enzyme. The most active compound was Z-21-hydroxyiminopregna-5,17(20)-dien-3β-ol (9) showing K(i) values of 44 and 3.4 nM for the human and rat enzymes, respectively, and a type II UV-difference spectrum indicating a coordinate bond between the oxime group and the heme iron. In contrast to the pregnenolones which showed no inhibition of 5α-reductase isozymes 1 and 2, the progesterones 16, 17, 20, 21, and 23 showed marked inhibition, especially toward the type 2 enzyme. Compounds 17 and 20 were identified as potent dual inhibitors of both P450 17 and 5α-reductase. Tested for selectivity, the most potent P450 17 inhibitors 9, 10, and 14 showed no or only marginal inhibition of P450 arom, P450 scc, and P450 TxA2. Selected compounds were tested for inhibition of the target enzymes using whole-cell assays. Compounds 9-11 strongly inhibited P450 17 being coexpressed with NADPH-P450 reductase in E. coli cells, and 16, 20, and 23 markedly inhibited 5α-reductase expressed in HEK 293 cells. Tested for in vivo activity, 9 (0.019 mmol/kg) decreased the plasma testosterone concentration in rats after 2 and 6 h by 57% and 44%.

Proficient synthesis of biologically active pregnane derivatives and its glycoside - Experimental and theoretical approach

Sethi, Arun,Bhatia, Akriti,Maurya, Atul,Panday, Anil,Bhatia, Gitika,Shrivastava, Atul,Singh, Ranvijay Pratap,Prakash, Rohit

, p. 112 - 124 (2013)

Synthesis of a number of pregnane derivatives including the glycoside has been described in detail. These compounds were synthesized by reaction of 3β-acetoxy-5, 16-pregnadiene-20-one, derived from diosgenin and then treating it with different nucleophilic reagents. The structures of these newly synthesized compounds were established on the basis of their physical, chemical and spectral data. The molecular geometry of compounds were calculated in ground state by density functional theory method (DFT/B3LYP) using 6-31G (d,p) basis set. 1H NMR chemical shifts were also studied using gauge-including atomic orbital (GIAO) approach, which were found in good agreement with the experimental values. The study of electronic properties such as UV-Vis spectral analysis, HOMO and LUMO energy calculations were performed with time dependent DFT (TD-DFT). Global and local reactivity descriptors were calculated to study the reactive sites within the molecules. These compounds were also evaluated for their anti-dyslipidemic (Triton model) and in vitro anti-oxidant activities. Out of these, compound 9 showed potent anti-dyslipidemic and anti-oxidant activity.

Reactivity of steroidal 1-azadienes toward enamines: an approach to novel chiral penta- And hexacyclic steroids

Lopes, Susana M. M.,Santos, Joana R. C.,Pinho e Melo, Teresa M. V. D.

, p. 1122 - 1132 (2021/02/16)

The chemical behavior of steroidalN-sulfonyl-1-azadienes toward carbonyl compounds, in the presence of pyrrolidine, is described. With aldehydes, these azadienes participate in hetero-Diels-Alder reactions with thein situgenerated enamines. The stereoselectivity results from the approach of the dienophiles from the less hindered α-face of the steroid, with the pyrrolidine moietyendoand retention of the enaminetransgeometry. This diastereoselective synthetic methodology led to a new class of chiral pentacyclic steroids. Interestingly, the studied steroidal scaffolds follow a different mechanistic pathway with cyclic ketones. They undergo a diastereoselective annulation reaction, under enamine catalysis, affording chiral hexacyclic steroids.

PREGNANE-OXIMINO-AMINOALKYLETHERS AND PROCESS FOR PREPARATION THEREOF, USEFUL AS ANTIDIABETIC AND ANTIDYSLIPIDEMIC AGENTS

-

Page/Page column 12, (2014/08/07)

The present invention relates to the synthesis of pregnane-oximino-aminoalkyl-ethers and their antidiabetic and antidyslipidemic activities. More particularly, the invention relates to the synthesis of compounds of formula 3 and biological profile thereof. Further the invention relates to compounds of formula 3 and pharmaceutically acceptable salts thereof.

Expeditious and convenient synthesis of pregnanes and its glycosides as potential anti-dyslipidemic and anti-oxidant agents

Sethi, Arun,Maurya, Atul,Tewari, Vibha,Srivastava, Sanjay,Faridi, Shaheen,Bhatia, Gitika,Khan,Khanna,Saxena

, p. 4520 - 4527 (2008/03/13)

A series of new pregnane derivatives and its glycosides were synthesized in order to find new 'leads' against some important targets. The 3β-hydroxy-16α-(2-hydroxy ethoxy) pregn-5-en-20-one (5) was synthesized from 3β-hydroxy-5,16-pregnadiene-20-one (2) by adopting general modified procedure using BF3:Et2O as a catalyst. Reduction of 5, with sodium borohydride yielded 3β,20β-dihydroxy-16α-(2-hydroxy ethoxy) pregn-5-en (7) as the major isolable product. O-alkylation of the C-20-oxime-pregnadiene (9) with 1,5-dibromopentane yielded 20-(O-5-bromopentyl)-oximino-3β-hydroxy-pregn-5,16-diene (11). Synthesis of C-16 substituted pregnane glycosides (20) and (21) were accomplished with the imidate method using BF3:Et2O. The synthesis of 4-chlorobenzoate (3) and 2-chlorobenzoate (4), derivatives of 2 were also accomplished. These compounds were evaluated for their anti-dyslipidemic and anti-oxidant activity and amongst them compounds 3 and 7 showed more lipid lowering and anti-oxidant activity.

Post a RFQ

Enter 15 to 2000 letters.Word count: 0 letters

Attach files(File Format: Jpeg, Jpg, Gif, Png, PDF, PPT, Zip, Rar,Word or Excel Maximum File Size: 3MB)

1

What can I do for you?
Get Best Price

Get Best Price for 1045-71-2